Image
Image

BioCina Resources Hub

Curated insights, technical guides, and industry updates from a global CDMO leader
Filter by:
Filters
Featured image for “What Is Cytotoxic Drug Manufacturing?”

What Is Cytotoxic Drug Manufacturing?

Cytotoxic drug manufacturing is a specialized area of pharmaceutical production focused on the safe handling, formulation, and fill-finish of compounds that are toxic…
Featured image for “Why Blow Fill Seal Technology Is Growing in Pharmaceutical Manufacturing”

Why Blow Fill Seal Technology Is Growing in Pharmaceutical Manufacturing

Blow fill seal technology is one of the fastest-growing segments in sterile pharmaceutical manufacturing. A single continuous automated process forms,…
Featured image for “What Is an Isolator Filling Workcell?”

What Is an Isolator Filling Workcell?

An isolator filling workcell is a robotic, closed-system aseptic filling platform designed to eliminate human presence from the critical fill…
Featured image for “BioCina Initiates Comprehensive Manufacturing Program for Patrys’ Proprietary Injectable Therapeutic to Alleviate Delirium”

BioCina Initiates Comprehensive Manufacturing Program for Patrys’ Proprietary Injectable Therapeutic to Alleviate Delirium

BioCina Pty Ltd., announced it has initiated a comprehensive CMC (Chemistry, Manufacturing, and Controls) program for the advancement of RLS-2201.…
Featured image for “Agility in Biomanufacturing: The Key to Overcoming Uncertainty”

Agility in Biomanufacturing: The Key to Overcoming Uncertainty

In today’s biopharma landscape, resilience isn’t enough — CDMOs must also be agile. Agility enables clients to adjust quickly to…
Featured image for “BioCina Announces Appointment of Dr. Thomas Broudy as Chief Executive Officer”

BioCina Announces Appointment of Dr. Thomas Broudy as Chief Executive Officer

BioCina, a leading pharmaceutical contract development and manufacturing organization (CDMO), today announced that Dr. Thomas Broudy has been appointed as…
Featured image for “What’s next for mRNA after COVID-19?”

What’s next for mRNA after COVID-19?

The pandemic proved that mRNA-based vaccines could be developed, manufactured, and distributed globally in record time. But the real promise…
Featured image for “Expanding LNP Applications Beyond mRNA Vaccines”

Expanding LNP Applications Beyond mRNA Vaccines

Lipid nanoparticles (LNPs) have transformed how we deliver mRNA. But their role in modern medicine is just beginning. In this…
Featured image for “Integrated mRNA-LNP Manufacturing Services”

Integrated mRNA-LNP Manufacturing Services

Thousands of mRNA-based vaccines and therapies are in development, but progressing from discovery to clinical trials is far from simple.…
Image

Looking for Something Specific?

If you can't find what you need, our team can provide tailored resources and program-specific information to help move your program forward.